Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.18%
#3 CoW Protocol CoW Protocol +41.66%
#4 Glidr Glidr +36.87%
#5 Humanity Humanity +25.34%
#6 Walrus Walrus +23.68%
#7 Codatta Codatta +19.58%
#8 Enso Enso +18.19%
#9 The Black Bull The Black Bull +15.04%
#10 Collector Crypt Collector Crypt +14.18%
Coin of the day
EXOD EXOD
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Peringkat dalam Saham #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Harga Saham
$0.6
Terakhir disinkronkan: 2024-08-14
Kapitalisasi Pasar
$2.09M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
SG
Perdagangan ASLAN Pharmaceuticals Limited (ASLN)

Kategori

Healthcare
Rasio P/S untuk ASLAN Pharmaceuticals Limited (ASLN)
Rasio P/S per August 2026 TTM: 64.76
Menurut laporan keuangan dan harga saham terbaru dari ASLAN Pharmaceuticals Limited, rasio P/S saat ini (TTM) adalah 64.76. Pada akhir 2022, rasio P/S perusahaan adalah 0.00.
Riwayat rasio P/S untuk ASLAN Pharmaceuticals Limited dari 2014 hingga 2026
Rasio P/S pada akhir setiap tahun
Tahun Rasio P/S Mengubah
2026 (TTM) 64.76 28,056.61%
2023 0.23 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 -100.00%
2019 7.03 0.00%
2018 0.00 0.00%
2017 0.00 -100.00%
2016 4.07 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
Rasio P/S untuk perusahaan sejenis atau pesaing
Perusahaan Rasio P/S Perbedaan Rasio P/S Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -84.30%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -84.36%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -92.68%
BE